Lv01
0 积分 2026-01-20 加入
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
1小时前
待确认
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
13天前
已完结
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-Asia
15天前
已完结
Hierarchical Testing of a Primary and a Secondary Endpoint in a Group Sequential Design With Different Information Times
1个月前
已完结
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study
1个月前
已完结
Lung Adenocarcinoma
1个月前
已关闭
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
2个月前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
2个月前
已关闭
New standards and new constraints redefine treatment sequencing in platinum-resistant ovarian cancer
2个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
2个月前
已完结
Preparing for Reality: A Randomized Trial on Immersive Virtual Reality for Bronchoscopy Training
皖公网安备34019202002308
